CYP19A1 fine-mapping and Mendelian randomization: estradiol is causal for endometrial cancer

- Thompson, Deborah J., O'Mara, Tracy A., Martin, Lynn, Hodgson, Shirley, Michailidou, Kyriaki, Tyrer, Jonathan P., Maranian, Mel J., Hall, Per, Czene, Kamila, Darabi, Hatef, Li, Jingmei, Fasching, Peter A., Glubb, Dylan M., Ashton, Katie, Proietto, Tony, Otton, Geoffrey, Scott, Rodney J, McEvoy, Mark, Attia, John, Holliday, Elizabeth G., Painter, Jodie N., Cheng, Timothy, Folkerd, Elizabeth, Doody, Deborah, Dennis, Joe, Webb, Penelope M., Gorman, Maggie

Impact of CYO19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial

- Johansson, Harriet, Gray, Kathryn P., Colleoni, Marco, Rabaglio, Manuela, Price, Karen N., Coates, Alan S., Gelber, Richard D., Goldhirsch, Aron, Kammler, Roswitha, Bonanni, Bernardo, Walley, Barbara A., TEXT principal investigators,, Pagani, Olivia, Chirgwin, Jaqueline, Francis, Prudence, Regan, Meredith M., Viale, Giuseppe, Aristarco, Valentina, Macis, Debora, Puccio, Antonella, Roux, Susanne, Maibach, Rudolf